latest news in companies
Utah Residents Challenge Kevin O'Leary's Proposed Hundred-Billion-Dollar AI Megaproject
Salt Lake City, Tuesday, 12 May 2026.
Kevin O’Leary faces intense Utah backlash over a proposed AI data center. Projected to consume double the state’s annual energy, the project sparked controversial claims of foreign proxy interference.
Spring and Mulberry Recalls Entire Chocolate Lineup Over Salmonella Risk
New York, Tuesday, 12 May 2026.
In May 2026, Spring and Mulberry recalled its entire chocolate lineup. Remarkably, a single batch of dates triggered this costly supply chain crisis, despite all products testing negative for salmonella.
Nvidia Secures the Future of Artificial Intelligence With a $40 Billion Investment Strategy
Santa Clara, Monday, 11 May 2026.
In early 2026, Nvidia deployed $40 billion to fund its own customers, creating a strategic financial loop to sustain the artificial intelligence ecosystem and secure long-term market dominance.
Frame Security Raises $50 Million to Shield Corporations from Evolving Deepfake Threats
San Francisco, Monday, 11 May 2026.
With 90% of data breaches involving human error, Frame Security just secured $50 million to train employees against sophisticated AI deepfakes using dynamic, real-world attack simulations.
New Horizon Aircraft Secures $20 Million to Fuel Hybrid-Electric Flight Development
New York, Monday, 11 May 2026.
Showcasing strong investor appetite for next-generation aviation, pre-revenue New Horizon Aircraft secured $20 million this May to accelerate the development of its innovative hybrid-electric aircraft.
JetBlue Sparks Backlash by Denying Hotel Costs to Stranded Passengers After St. Lucia Bird Strike
Vieux Fort, Monday, 11 May 2026.
JetBlue legally denied hotel rooms to stranded St. Lucia passengers following a mid-May bird strike, exposing the stark tension between strict airline cost-control measures and long-term brand reputation.
Alvotech Completes Key FDA Inspection to Keep US Expansion Plans on Schedule
Reykjavik, Monday, 11 May 2026.
Following a critical FDA inspection in Iceland, Alvotech remains on track for its second-quarter US product submissions, prioritizing long-term market growth despite a recent 20% quarterly revenue dip.
